Nā huahana
-
17 Nā ʻano o ka HPV (16/18/6/11/44 Ke kikokiko ʻana)
He kūpono kēia pahu no ka ʻike qualitative o 17 mau ʻano papillomavirus (HPV) ʻano (HPV 6, 11, 16,18,31, 33,35, 39, 44,45, 51, 52.56,58, 59,66, 68) nā ʻāpana ʻakika nucleic kikoʻī i loko o ka laʻana mimi, ka laʻana o ka puʻu ʻana o ka ʻōpū o ka wahine a me ka laʻana o ka swab vaginal wahine, a me ka HPV 16/18/6/11/44 e paʻi ana e kōkua i ka ʻike a mālama ʻana i ka maʻi HPV.
-
ʻO Borrelia Burgdorferi Nucleic Acid
He kūpono kēia huahana no ka ʻike in vitro qualitative o Borrelia burgdorferi nucleic acid i loko o ke koko holoʻokoʻa o nā maʻi, a hāʻawi i nā ala kōkua no ka ʻike ʻana i nā maʻi maʻi Borrelia burgdorferi.
-
ʻO Chikungunya Fever IgM/IgG Antibody
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o nā antibodies Chikungunya Fever in vitro ma ke ʻano he hōʻailona kōkua no ka maʻi ʻo Chikungunya Fever.
-
Mycobacterium Tuberculosis Isoniazid Resistance Mutation
He kūpono kēia kit no ka ʻike qualitative o nā pae hoʻololi nui i nā laʻana sputum kanaka i hōʻiliʻili ʻia mai nā maʻi maʻi maʻi Tubercle bacillus e alakaʻi i ka mycobacterium tuberculosis isoniazid resistance: InhA promoter region -15C>T, -8T>A, -8T>C;ʻĀpana hoʻolaha AhpC -12C>T, -6G>A;homozygous mutation o KatG 315 codon 315G>A, 315G>C .
-
Staphylococcus Aureus a me ka Methicillin-Resistant Staphylococcus Aureus
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o staphylococcus aureus a me nā methicillin-resistant staphylococcus aureus nucleic acids i loko o nā laʻana sputum kanaka, nasal swab samples a me nā ʻili a me nā ʻiʻo palupalu nā maʻi maʻi i vitro.
-
Mea Analyzer Immunoassay Fluorescence
ʻO ka Fluorescence Immunoassay Analyzer kahi ʻōnaehana immunochromatographic analyzer fluorescence e kōkua i ka ʻike ʻana i nā kūlana e like me ka mumū, nā maʻi cardiovascular, nā maʻi kanesa, a me nā mea ʻē aʻe.
-
Zika Virus
Hoʻohana ʻia kēia pahu e ʻike pono i ka Zika virus nucleic acid i loko o nā laʻana serum o nā maʻi i manaʻo ʻia he maʻi Zika virus in vitro.
-
Zika Virus Antigen
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka maʻi Zika i loko o nā laʻana koko kanaka i loko o vitro.
-
Zika Virus IgM/IgG Antibody
Hoʻohana ʻia kēia kit no ka ʻike qualitative o Zika virus antibodies in vitro ma ke ʻano he hōʻailona kōkua no ka maʻi maʻi Zika.
-
25-OH-VD pahu ho'āʻo
Hoʻohana ʻia kēia kit e ʻike nui i ka neʻe ʻana o ka 25-hydroxyvitamin D(25-OH-VD) i loko o ka serum kanaka, plasma a i ʻole nā mea hoʻohālike koko holoʻokoʻa in vitro.
-
TT4 pahu ho'āʻo
Hoʻohana ʻia ka pahu no ka ʻike in vitro quantitative o ka ʻike ʻana o ka nui o ka thyroxine (TT4) i loko o ka serum kanaka, plasma a i ʻole nā mea hoʻohālike koko holoʻokoʻa.
-
TT3 pahu ho'āʻo
Hoʻohana ʻia ka kit e ʻike nui i ka neʻe ʻana o ka triiodothyronine (TT3) i loko o ka serum kanaka, plasma a i ʻole nā koko koko holoʻokoʻa in vitro.
